Mosaic Family Wealth, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mosaic Family Wealth, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$294,000
-2.6%
3,2690.0%0.08%
-9.5%
Q3 2021$302,000
-10.1%
3,269
-24.3%
0.08%
-13.4%
Q2 2021$336,000
+4.3%
4,3190.0%0.10%
+4.3%
Q1 2021$322,000
-53.9%
4,319
+5.3%
0.09%
-60.3%
Q4 2020$699,000
+55.7%
4,100
+28.1%
0.23%
+39.3%
Q3 2020$449,000
-16.4%
3,200
-4.5%
0.17%
-24.3%
Q2 2020$537,000
+99.6%
3,350
+21.8%
0.22%
+63.2%
Q1 2020$269,000
-24.2%
2,7500.0%0.14%
-4.9%
Q4 2019$355,000
+71.5%
2,7500.0%0.14%
+68.2%
Q3 2019$207,000
-41.0%
2,750
+19.0%
0.08%
-42.2%
Q2 2019$351,000
+28.1%
2,311
+0.5%
0.15%
+33.6%
Q1 2019$274,000
+32.4%
2,300
+21.1%
0.11%
+27.9%
Q4 2018$207,000
-6.8%
1,9000.0%0.09%
-5.5%
Q3 2018$222,000
-11.6%
1,9000.0%0.09%
-4.2%
Q2 2018$251,000
+78.0%
1,9000.0%0.10%
+82.7%
Q1 2018$141,000
+33.0%
1,9000.0%0.05%
+33.3%
Q4 2017$106,000
+23.3%
1,9000.0%0.04%
+18.2%
Q3 2017$86,000
+34.4%
1,9000.0%0.03%
+22.2%
Q2 2017$64,000
+14.3%
1,9000.0%0.03%
+12.5%
Q1 2017$56,000
+7.7%
1,9000.0%0.02%0.0%
Q4 2016$52,000
-46.9%
1,900
+18.8%
0.02%
-47.8%
Q3 2016$98,000
+216.1%
1,6000.0%0.05%
+206.7%
Q2 2016$31,0000.0%1,6000.0%0.02%0.0%
Q1 2016$31,000
+933.3%
1,600
+1500.0%
0.02%
+1400.0%
Q4 2015$3,0001000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders